Across TCGA pan-cancer cohorts, GOLGA6L3 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated GOLGA6L3 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GOLGA6L3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA6L3 expression acts as an unfavorable survival marker.

UCEC are the cancer types where GOLGA6L3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.654	0.927	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: GOLGA6L3 tumor-vs-normal RNA expression · all GOLGA6L3 data types